Managing big issues on lean evidence: Treating obesity hypertension

Nephrology Dialysis Transplantation

Volumn 17, Issue 3, 2002, Pages 353-355

  Sharma, Arya M ^a,b   Engeli, Stefan ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Body weight; Hypertension; Obesity; Therapy; Treatment; Weight gain

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTIOBESITY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG EFFICACY; HEART OUTPUT; HUMAN; HYPERTENSION; METABOLIC DISORDER; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SODIUM INTAKE; VASCULAR RESISTANCE; WEIGHT REDUCTION;

EID: 0036192779     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.3.353     Document Type: Article

References (25)

1. Secular blood pressure trends in normotensive persons: The Framingham Study
2. Obesity, alcohol consumption and blood pressure in Australian men and women
3. Obesity-induced hypertension: New concepts from the emerging biology of obesity
4. Role of adipose tissue for cardiovascular-renal regulation in health and disease
5. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure
6. Long-term weight loss and changes in blood pressure: Results of the Trials of Hypertension Prevention, Phase II
7. Choice of drug treatment for obesity-related hypertension: Where is the evidence?
8. Dimorphic cardiac adaptation to obesity and arterial hypertension
9. Cardiovascular regulation in obesity-induced hypertension
10. Metabolic considerations in the choice of therapy for the patient with hypertension
11. Metabolic considerations in hypertension
12. Microalbuminuria in obese patients with or without hypertension
13. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss
14. Predicting sudden death in the population: The Paris Prospective Study I
15. Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity
16. Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis
17. Effects of obesity on pharmacokinetics: Implications for drug therapy
18. Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers
19. Liver fibrosis in overweight patients
20. Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss
21. Obesity as a determinant for response to antihypertensive treatment
22. Lisinopril versus hydrochlorothiazide in obese hypertensive patients: A multicenter placebo-controlled trial
23. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults
24. Urinary sodium excretion and cardiovascular mortality in Finland: A prospective study